GLOBENEWSWIRE Generex Biotechnology to Hold Conference Call On Friday to Update Investors On Phase III Trial of Generex Oral-lyn(tm) and Other Corporate Activities
Generex Biotechnology to Hold Conference Call On Friday to Update Investors On Phase III Trial of Generex Oral-lyn(tm) and Other Corporate Activities
Friday, March 13 At 11 AM Eastern Time
WORCESTER, Mass., Mar 11, 2009 (GlobeNewswire via COMTEX) -- Generex Biotechnology Corporation (GNBT) Click for Detail
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.